Detalhe da pesquisa
1.
Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals.
Pediatr Pulmonol
; 57(10): 2420-2427, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791790